BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 24861246)

  • 1. Which imaging technique should we use in the follow up of gynaecological cancer?
    Testa AC; Di Legge A; Virgilio B; Bonatti M; Manfredi R; Mirk P; Rufini V
    Best Pract Res Clin Obstet Gynaecol; 2014 Jul; 28(5):769-91. PubMed ID: 24861246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiological assessment of gynecologic malignancies.
    Bell DJ; Pannu HK
    Obstet Gynecol Clin North Am; 2011 Mar; 38(1):45-68, vii. PubMed ID: 21419327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging techniques for the evaluation of cervical cancer.
    Testa AC; Di Legge A; De Blasis I; Moruzzi MC; Bonatti M; Collarino A; Rufini V; Manfredi R
    Best Pract Res Clin Obstet Gynaecol; 2014 Jul; 28(5):741-68. PubMed ID: 24861248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic and interventional radiology in gynecologic neoplasms.
    Thorvinger B
    Acta Radiol Suppl; 1992; 378 ( Pt 3)():93-108. PubMed ID: 1323200
    [No Abstract]   [Full Text] [Related]  

  • 5. Imaging of uterine cancer.
    Akin O; Mironov S; Pandit-Taskar N; Hann LE
    Radiol Clin North Am; 2007 Jan; 45(1):167-82. PubMed ID: 17157628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDG-PET for management of cervical and ovarian cancer.
    Havrilesky LJ; Kulasingam SL; Matchar DB; Myers ER
    Gynecol Oncol; 2005 Apr; 97(1):183-91. PubMed ID: 15790456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of a prospective study with comparison of clinical, endosonographic, computed tomography, magnetic resonance imaging and pathologic staging of advanced gynecologic carcinoma and recurrence.
    Houvenaeghel G; Delpero JR; Rosello R; Resbeut M; Viens P; Jacquemier J; Noirclerc M; Guerinel G
    Surg Gynecol Obstet; 1993 Sep; 177(3):231-6. PubMed ID: 8356495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous positron emission tomography/magnetic resonance imaging for whole-body staging in patients with recurrent gynecological malignancies of the pelvis: a comparison to whole-body magnetic resonance imaging alone.
    Grueneisen J; Beiderwellen K; Heusch P; Gratz M; Schulze-Hagen A; Heubner M; Kinner S; Forsting M; Lauenstein T; Ruhlmann V; Umutlu L
    Invest Radiol; 2014 Dec; 49(12):808-15. PubMed ID: 25010207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of PET in gynecologic malignancy.
    Grigsby PW
    Curr Opin Oncol; 2009 Sep; 21(5):420-4. PubMed ID: 19553814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The optimal imaging in gynecological oncology].
    Fischerová D; Burgetová A
    Ceska Gynekol; 2014 Dec; 79(6):425-35. PubMed ID: 25585551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging techniques in the staging of gynecologic malignancy.
    Hann LE; Crivello MS
    Clin Obstet Gynecol; 1986 Sep; 29(3):715-27. PubMed ID: 3530576
    [No Abstract]   [Full Text] [Related]  

  • 12. PET/CT in gynecologic cancer: present applications and future prospects--a clinician's perspective.
    Amit A; Schink J; Reiss A; Lowenstein L
    Obstet Gynecol Clin North Am; 2011 Mar; 38(1):1-21, vii. PubMed ID: 21419325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current concepts in the diagnosis and management of endometrial and cervical carcinomas.
    Tirumani SH; Shanbhogue AK; Prasad SR
    Radiol Clin North Am; 2013 Nov; 51(6):1087-110. PubMed ID: 24210446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffusion-weighted imaging and dynamic contrast-enhanced MRI in assessing response and recurrent disease in gynaecological malignancies.
    Hameeduddin A; Sahdev A
    Cancer Imaging; 2015 Mar; 15(1):3. PubMed ID: 25889065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Magnetic resonance tomography in oncologic gynecology].
    Dudarev AL; Vinokurov VL; Shelkoplias EN; Goritskaia IV
    Vestn Rentgenol Radiol; 1993; (5):14-5. PubMed ID: 7801576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo magnetic resonance spectroscopy of gynaecological tumours at 3.0 Tesla.
    Booth SJ; Pickles MD; Turnbull LW
    BJOG; 2009 Jan; 116(2):300-3. PubMed ID: 19076962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of X-ray CT and magnetic resonance imaging in the diagnosis of gynecological malignant tumor].
    Suzuki M
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Aug; 41(8):942-52. PubMed ID: 2809344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of [18F]-fluorodeoxyglucose positron emission tomography for the initial detection, staging, search for recurrences and restaging of gynaecological and breast cancers].
    Grahek D; Barranger E; Daraï E; Uzan S; Talbot JN
    Gynecol Obstet Fertil; 2005 Jun; 33(6):371-81. PubMed ID: 15927502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations.
    Salani R; Backes FJ; Fung MF; Holschneider CH; Parker LP; Bristow RE; Goff BA
    Am J Obstet Gynecol; 2011 Jun; 204(6):466-78. PubMed ID: 21752752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use and abuse of imaging in gynecologic cancer.
    Lewis E
    Cancer; 1987 Oct; 60(8 Suppl):1993-2009. PubMed ID: 3308061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.